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ABSTRACT 
Medications designed to treat symptoms and cure chronic diseases can also cause unanticipated problems with the reproductive system; even in therapeutic 
doses. This study was therefore conducted on a commonly used polyherbal antihypertensive product on the Ghanaian market to ascertain its reproductive 
toxicity in both females and males. Couple-mediated and male-specific toxicities (endpoints) that measure characteristics for successful sexual performance 
and procreation were investigated in ICR mice. Data obtained indicated that the product did not have any negative effect on mating behavior and fertility in 
both female and male mice. It did not affect gestation; neither did it have detrimental effect on litter number and litter weight, live birth and weaning index. 
The product also did not affect caudal epididymis and testis weight. Spermatozoa concentrations, spermatozoa motility and viability after semen analysis were 
also not affected after  semen analysis. The  endpoints that measure  characteristics  for  successful  sexual performance and  procreation  were  not adversely 
affected with the use of the product under study, therefore, as far as reproductive toxicity is concerned, the polyherbal antihypertensive mixture is safe to use 
within limits of the doses administered in this study. 
Keywords:  Couple-mediated  toxicity,  Spermatozoa  concentration,  Mating  Index,  Fertility  Index,  Weaning  Index,  Live  Birth  Index,  Polyherbal 
antihypertensive (PHA)  
 
INTRODUCTION 
Reproductive toxicity is “any effect of chemicals that would 
interfere  with  reproductive  ability  and  capacity”  with 
subsequent  effect  on  lactation  and  the  development  of  the 
offspring.
1 Medications designed to treat symptoms and cure 
chronic diseases can also cause unanticipated problems with 
the reproductive system; even in therapeutic doses.
2,  3 Such 
medication  could  affect  the  female  reproduction  by 
decreasing  libido  (and  hence  mating)  and  having  negative 
effects on ovulation, fertilization, implantation, and gestation. 
They could also affect the developing implant and cause still 
birth or could affect the health of the offspring. Similarly, 
these  medications  could  also  affect  male  reproductive 
abilities by decreasing libido, causing impotence (and hence 
reducing mating), and/or decreasing spermatozoa quantity or 
quality  which  adversely  affect  fertilization. 
Pharmacologically  mediated  male  infertility  can  be  an 
unintended  effect  of  medical  treatment  or an  unanticipated 
consequence of drug use.
4  
In Ghana, herbal remedies have become widely accepted in 
the  treatment  of  hypertension,  a  chronic  disease  of  adults 
most of whom are in the reproductive ages and beyond. Most 
male  patronize  these  product  because  of  knowledge  that 
many  of  the  allopathic  antihypertensives  are  commonly 
associated  with  erectile  dysfunction
5and  other  reproductive 
system impairments.
6 This prompted the present reproductive 
toxicity  studies  on  a  commonly  used  polyherbal 
antihypertensive  mixture  in  Ghana.  This  polyherbal  is  a 
prepackaged aqueous preparation made from bark and leaves 
of Persea americana and Vernonia amygdalina respectively. 
Persea americana (avocado, alligator pear or butter pear) is 
known  to  have  hypotensive  or  antihypertensive  effects,
7 
wound  healing  properties,
8  antibacterial  activity
9  and 
hypoglycaemic effects.
10 Vernonia amygdalina (“bitter leaf”) 
is  a  widely  used  medicinal  plant  in  Africa  for  its 
antihypertensive  effects.
11  Leaves  from  this  plant  serve  as 
culinary  herb  in  soup.
12  In  traditional  Nigerian  homes, 
extracts  of  the  plant  are  used  as  tonic  in  the  treatment  of 
cough, feverish condition, constipation and hypertension.
13, 14 
Vernonia amygdalina extracts may help suppress, delay, or 
kill  cancerous  cell  by  diverse  mechanisms.
15,  16  It  may 
provide  anti-oxidant  benefits,
17  strengthen  the  immune 
system  through  cytokine  regulation,
18  and  decrease  blood 
glucose.
19  
Koffuor  et  al.,  (2011  a)  reported  previously  that  the 
polyherbal anti-hypertensive preparation has CNS depressant, 
anxiolytic,  and  probably  muscle  relaxant  activity  which 
affects  neurological  behaviors.  Within  limits  of  acute  and 
delayed toxicity, however, the product is safe to use.
20 Sub-
chronic  toxicity  evaluation  of  this  polyherbal  mixture 
suggests that it may be safe to use when used in lower doses 
but  could  potentially  provoke  liver  and  kidney  damage  in 
higher doses.
21 Further studies have shown that the product 
shortens the onset of sleep and prolongs the duration of sleep 
possibly  by  inhibiting  CYP450  enzymes.  We  therefore 
proposed that caution should be taken on the concomitant use 
of  this  product  and  allopathic  antihypertensives  and/or 
hypno-sedatives as it could potentiate their activity.
22 Here 
we  report  on  the  reproductive  toxicity  of  this  polyherbal 
antihypertensive product in both male and female ICR mice. 
MATERIAL AND METHODS 
This  study  was  conducted  at  the  Department  of 
Pharmacology,  KNUST  in  compliance  with:  OECD 
Principles  of  Good  Laboratory  Practices  ENV/MC/CHEM 
(98)17,  EEC  Good  Laboratory  Practices  (90/18/EEC)  and 
FDA  Good  Laboratory  Practice  Standards  (Part  58  of  21 
CFR). 
Animals and Husbandry 
Imprint Control Region (ICR) mice at 4 weeks of age were 
obtained  from  the  Department  of  Pharmacology,  Animal 
House  and  acclimated  for  2  weeks  prior  to  initiation  of 
dosing. During this period, mice were observed (physical; in-
life) daily and weighed. At initiation of treatment, animals 
were approximately 6-7 weeks old. The mean weight for the Koffuor George Asumeng et al. IRJP 2012, 3 (5) 
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males was 29.2 g and the females 25.6 g. The females were 
nulliparous  and  non-pregnant.  Individual  weights  of  mice 
placed on test were  within ± 20% of the mean weight for 
each sex. Animals were housed in stainless steel wire mesh 
cages during the acclimation and the experimental periods. 
The  mice  were  kept  under  ambient  light/dark  cycle,  room 
temperature  and  relative  humidity.    The  animal  had  free 
access to pelleted mice chow (GAFCO, Tema, Ghana) and 
water presented to them daily.  
The Polyherbal Antihypertensive and Dosing 
The polyherbal product under study is an aqueous preparation 
made from stem bark and leaves of Persea americana, and 
Vernonia amygdalina obtained from forests in Ghana. Dosing 
of  the  product  was  done  based  on  the  manufacturer’s 
recommendations.  ICR  mice  were  grouped  (n=5)  and 
received vehicle or 36, 72, or 180 mg/kg of the product by 
gavage. Dosing was once daily at a volume of 10 ml/kg body 
weight. Individual dose volumes were calculated based on the 
animal’s most recent recorded body weight.  The oral route of 
administration  was  used  because  it  is  the  intended  human 
exposure route. 
Reproductive Toxicity in Female ICR Mice 
The reproductive toxicity in female mice was carried out by a 
method described by Ansah et al., (2010).
23 Four groups of 
female ICR mice (n=10) were used in the study. Treatment 
group I was the control and received vehicle only. Treatment 
groups II, III, and IV received 36, 72, and 180 mg/kg of PHA 
(respectively)  daily  for  two  weeks.  After  the  two-week 
treatment  period,  the  female  mice  were  regrouped  by 
subdividing each treatment group into two (n=5) and labeled 
as follows: IA, IB, IIC, IID, IIIE, IIIF, IVG, and IVH. Two 
male  mice  were  introduced  into  each  of  the  eight  female 
groups. Treatment of female mice in groups IA, IIC, IIIE, and 
IVG was continued with vehicle, 36, 72, and 180 mg/kg PHA 
respectively through the gestation period and up to 21 days 
after parturition. Treatment with vehicle and PHA in groups 
IB, IID, IIIF, and IVH was discontinued just after males were 
cohabited with the females. Formation of vaginal plug was 
taken as  evidence  of  successful  mating.  The  time  taken to 
mate  after  cohabitation,  number  of  mice  mated, 
impregnation, fertility, gestation period, litter size, live births 
and offspring survival were observed. Reproductive indices 
which include Mating Index (MI), Fertility Index (FI), Live 
Birth Index (LBI) and Weaning Index (WI) were determined. 
Reproductive Toxicity in Male ICR Mice 
Four  groups  of  male  mice  (n=5)  were  used  in  the  study. 
Treatment  group  I  was  the  control  and  animal  received 
vehicle only. Treatment groups II, III, and IV received 36, 72, 
and 180 mg/kg of PHA (respectively) daily for 21 days. After 
the  treatment  period,  the  male  mice  were  introduced  into 
groups of female mice as described as follows. Female mice 
were grouped into eight (n=5) as follows: A, B, C, and D. 
Two male mice from group I (control) were introduced into 
female  group  A;  two  36  mg/kg  PHA-treated  males  from 
group II were introduced into female group B; two 72 mg/kg 
PHA-treated  males  from  group  III  were  introduced  into 
female group C; and two 180 mg/kg PHA-treated males from 
group IV were introduced into female group D. Formation of 
vaginal  plug  was  taken  as  evidence  of  successful  mating. 
Time taken to mate, number of mice mated, impregnation, 
fertility, gestation period, litter size, live births and offspring 
survival were observed. Mating Index (MI), Fertility Index 
(FI), Live Birth Index (LBI) and Weaning Index (WI) were 
determined 
Evaluation of Fertility in Male ICR Mice 
Epididymal Spermatozoa Assay  
For epididymal spermatozoa counts, the method described by 
Meistrich (1989)
24 was used with slight modifications. Four 
groups of male mice (n=5) were used in the study. Group 1; 
the control was given received vehicle only. Groups 2, 3, and 
4 received 36, 72 and 180 mg/kg respectively of PHA daily 
for 3 weeks. Animals from each group were then euthanized 
by cervical dislocation and the wet weight of the left caudal 
epididymis and testis was taken and recorded to the nearest 
0.1 mg. To prevent the loss of secretory fluid, the base of 
each  seminal  vesicle  was  grasped  with  forceps  before 
removing.  By  mincing  the  caudal  epididymis  in  20  ml 
physiological saline at 37°C, a spermatozoa suspension was 
obtained for evaluation of semen parameters using the Ceti 
magnum-T/trinocular microscope  for fluorescence (Medline 
Scientific limited, UK) under an objective lens magnification 
40X as follows:  
Spermatozoa Concentration 
A drop of the spermatozoa suspension was delivered onto the 
counting  chamber  of  the  Improved  Neubauer 
Haemocytometer  (Depth  0.1mm,  Area:  1/400  mm
2; 
Yancheng  Cordial  Lab  Glassware  Co.  Ltd,  Jiangsu,  China 
(Mainland)  and  allowed  to  stand  for  5  minutes  for 
sedimentation, after which spermatozoa were counted from 
five  large  squares  (volume:  0.5  mm
3)  and  spermatozoa 
concentration expressed as number of spermatozoa per ml. 
Spermatozoa Motility  
After introducing a drop of spermatozoa suspension onto the 
counting  chamber  of  the  Improved  Neubauer 
Haemocytometer,  non-motile  spermatozoa  numbers  were 
first determined from five large squares, followed by a total 
spermatozoa count (motile and non-motile). The number of 
motile  spermatozoa  was  calculated.  Spermatozoa  motility 
was  estimated as: percentage of motile spermatozoa to the 
total spermatozoa counted. 
Spermatozoa Viability 
This technique is used to differentiate between live and dead 
spermatozoa.  A  drop  of  the  eosin  stain  was  added  to  the 
spermatozoa  suspension  and  delivered  onto  the  counting 
chamber of the on the Improved Neubauer Haemocytometer 
and allowed to stand for 5 minutes at 37°C. On examination 
under the microscope (40X), the head of dead spermatozoa 
were stained red while the live spermatozoa were not stained. 
Spermatozoa viability  was  estimated as: percentage of live 
spermatozoa to the total spermatozoa counted. 
Statistical Analysis 
The  observations  are  presented  as  mean ±  SD.  Significant 
differences among means of the group were determined by 
one-way  ANOVA  using  Graph  Pad  Prism  for  windows 
version  5.0  (Graph  Pad  Software,  San  Diego,  CA,  USA) 
followed by Dunnet’s multiple comparison test with level of 
significance set at P ≤ 0.05. 
RESULTS 
Reproductive Toxicity in Female and Male ICR Mice 
Data  obtained  indicated  that  PHA  did  not  have  any 
detrimental  effect  on  mating  behavior  in  both  female  and 
male mice as time taken to mate after cohabitation between 
PHA-treatments and that of the control were not significantly 
different, and mating index was always 100 % (Table 1, 2, 
and 3). It was also observed that there were no serious effects 
on fertility as the lowest fertility index (recorded in only one 
treatment  group)  was  75  %  (Table  2).  Treatment  of  both 
female  and  male  mice  with  PHA  did  not  affect  gestation Koffuor George Asumeng et al. IRJP 2012, 3 (5) 
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period which was approximately 21 days. PHA did not have 
any effect on litter number and litter weight and all pregnant 
mice gave birth to live litter (live birth index was nearly 100 
%) with weights similar to untreated mice (Table 2 and 3). 
Almost all litter in all treatment groups was alive at day 21 
after birth; recording 100 % weaning index (Table 2 and 3).  
Evaluation of Fertility in Male ICR Mice 
Weights of the caudal epididymis recorded and that of the 
testis were not significantly different from the control (Table 
4).  Spermatozoa  concentrations,  spermatozoa  motility  and 
viability  after  semen  analysis  were  also  not  different  from 
that of the control group (Table 4). 
DISCUSSION 
Reproductive  toxicity  risk  assessment  to  evaluate  the 
potential  toxicity  of  drugs  to  the  human  male  and  female 
reproductive systems and to developing offspring focuses on 
reproductive system function as it relates to sexual behaviour, 
fertility, pregnancy  outcomes, and lactating ability, and the 
processes  that  can  affect  those  functions  directly.  The 
endpoints that measure characteristics that are necessary for 
successful  sexual  performance  and  procreation  are  couple-
mediated, female-specific, and male-specific.  
Couple-mediated endpoints are those in which both sexes can 
have a contributing role if both partners are exposed. These 
include  mating  rate,  time  to  mating  (time  to  pregnancy), 
pregnancy  rate,  delivery  rate,  gestation  length,  litter  size 
(total  and  live),  number  of  live  and  dead  offspring  (foetal 
death rate), offspring gender, birth weight, offspring survival, 
and  external  malformations  and  variations.  Male-specific 
endpoints of reproductive toxicity include monitoring organ 
weights  (testes,  epididymis,  seminal  vesicles,  prostate,  and 
pituitary) and spermatozoa evaluation (spermatozoa number 
count) and quality (morphology and motility). 
Although PHA did not have any adverse effects on mating 
behavior  in  both  females  and  males,  a  useful  indicator  of 
impaired  reproductive  function  may  be  the  length  of  time 
required for each pair to mate after the start of cohabitation. 
An increased interval between initiation of cohabitation and 
evidence of mating suggests abnormal oestrous cyclicity in 
the  female  or  impaired  sexual  behaviour  in  one  or  both 
partners.  A  fertility  index  between  80-100  %  as  observed 
confirms  the  “no-effect”  on  mating  behavior.  Sexual 
behaviour  reflects  complex  neural,  endocrine,  and 
reproductive organ interactions and is therefore susceptible to 
disruption  by  a  variety  of  toxic  agents  and  pathologic 
conditions. Interference with sexual behaviour in either sex 
by  drugs  represents  a  potentially  significant  reproductive 
problem which is an evidence of impaired sexual receptivity 
and copulatory behaviour. 
Treatments  did  not  affect  the  gestation  period,  however, 
significant  shortening  of  gestation,  can  lead  to  adverse 
outcomes of pregnancy such as decreased birth weight and 
offspring  survival.  Significantly  longer  gestation  may  be 
caused  by  failure  of  the  normal mechanism  for  parturition 
and may result in death or impairment of offspring if dystocia 
(difficulty in parturition) occurs. 
PHA  did  not  have  any  significant  effect  on  litter  size 
(number) and litter weight and live birth index which could 
imply  that  other  reproductive  endpoints  such  as  ovulation 
rate,  and  fertilization  rate  were  normal  and  implantation 
number was good. Furthermore, litter size, litter weight and 
live  birth  index  were  not  significantly  affect  probably 
indicating  that  there  were  no  pre-implantation  or  post-
implantation  losses,  as  well  as  internal  malformations  and 
variations which could affect the numbers of live and dead 
offspring. 
Birth weight measured on the day of parturition for the PHA 
treatments  and  the  control  were  not  significantly  different 
from each other. Birth weights, however, are influenced by 
intrauterine  growth  rates,  litter  size,  and  gestation  length 
(which were found to be normal). Individual pups in large 
litters tend to be smaller than pups in smaller litters. Thus, 
reduced birth weights attributed to large litter size was not 
considered an adverse effect. Weaning index recorded was 
100  %.  This  could  be  due  good  postnatal  structural  and 
functional  development  devoid  of  PHA  effect.  Offspring 
survival is dependent on birth weight, sex, and normality of 
the individual, as well as the litter size, lactational ability of 
the dam, and suckling ability of the offspring. Although all 
weight and survival endpoints can be affected by toxicity of 
an agent, either by direct effects on the offspring or indirectly 
through  effects  on  the  ability  of  the  dam  to  support  the 
offspring, PHA treatment had no effect. 
Weights  of  the  caudal  epididymis  and  that  of  the  testis 
recorded  were  not  significantly  different  from  the  control. 
Weight is an excellent index of either the biochemical or the 
anatomical  state  of  reproductive  organs.  The  male 
reproductive  organs  for  which  weights  may  be  useful  for 
reproductive risk assessment include the testes, epididymis, 
seminal  vesicles  (with  coagulating  glands),  and  prostate. 
Reproductive organ size (testes and seminal vesicles occupies 
a place of special importance among morphological measures 
because  of  its  direct  implication  in  fertility.  Reproductive 
organ  sizes  are  markers  of  the  timing  of  puberty  and 
testicular  weight  is  connected  total  spermatozoa  count  in 
mice. Since normal testis weight varies only modestly within 
a  given  test  species.  This  relatively  low  inter-animal 
variability  suggests  that absolute  testis  weight  should  be  a 
precise indicator of gonadal injury. 
Spermatozoa  concentrations,  spermatozoa  motility  and 
viability  after  semen  analysis  were  also  not  different  from 
that of the control group.  Although effects on spermatozoa 
production  can  be  reflected  in  other  measures  such  as 
testicular spermatid count or caudal epididymal weight, no 
surrogate  measures  are  adequate  to  reflect  effects  on 
spermatozoa morphology or motility. The ability to detect a 
decrease  in  testicular  spermatozoa  production  may  be 
enhanced if spermatid counts are available.  
It  can  be  concluded  that  the  endpoints  that  measure 
characteristics  that  are  necessary  for  successful  sexual 
performance  and  procreation  were  not  adversely  affected 
with the use of the product under study, therefore, as far as 
reproductive  toxicity  is  concerned,  the  polyherbal 
antihypertensive mixture is safe to use within limits of the 
doses administered in this study. 
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Table 1: Comparison of time to mate, number of mice mated, and number of females pregnant for female pretreatment with PHA for 14 days only prior to 
mating, and female mice pretreated with PHA for 14 days prior to mating with continuing treatment. 
Treatments  PHA Treatment  Time taken to mating 
(days) 
№ of mice mated  № of Pregnant 
females 
Pretreatment for 14 days 
followed by mating and 
continued treatment during 
gestation 
I A (control)  3.4 ± 0.83  5  4 
II C (36 mg/kg)  3.4 ± 0.89 
ns  5  5 
IIIE (72 mg/kg)  3.2 ± 0.83  
ns  5  4 
IVG (180 mg/kg)  3.2 ± 1.09  
ns  4  3 
Pre-treatment for 14 days 
only followed by mating 
IB (control)  3.4 ± 1.14  4  4 
IID (36 mg/kg)  3.4 ± 0.89  
ns  5  4 
IIIF (72 mg/kg)  3.4 ± 0.89  
ns  4  4 
IVH (180 mg/kg)  3.2 ± 1.09  
ns  5  4 
Values quoted are Means + SD (n=5). There were no significant different between treated groups and the control as established using one way Analysis of 
Variance (ANOVA). ns imply P > 0.05. 
 
Table 2: Comparison of reproductive indices for female pretreatment with PHA for 14 days only prior to mating, and female mice pretreated with PHA for 14 
days prior to mating with continuing treatment during gestation and up to 21 days after parturition. 
  PHA-
Treatments 
MI (%)  FI (%)  GP (days)  Litter №  LBI (%)  LW (g)  WI (%) 
Pretreatment for 14 
days followed by 
mating and 
continuing 
treatment during 
and after gestation 
I A (control)  100  80  21.0±0.32  10.4±0.51  100±0.00  1.60±0.083  100±0.00 
II C (36 mg/kg)  100  100  20.8±0.20 
ns  9.2±0.58  
ns  98.2±1.82 
ns  1.68±0.080  
ns  100±0.00  
ns 
IIIE (72 mg/kg)  100  80  21.6±0.24 
ns  10.2±0.58 
ns 
100±0.00  
ns  1.63 ±0.082  
ns 
94.8±3.37  
ns 
IVG (180 
mg/kg) 
100  75  21.4±0.24 
ns  9.0±0.45 
ns  100±0.00  
ns  1.62 ±0.65  
ns  100±0.00  
ns 
Pre-treatment for 14 
days  only followed 
by mating 
IB (control)  100  100  21.4±0.40  10.0±0.7  92.6±3.25  1.62 ±0.092  96.4±3.7 
IID (36 mg/kg)  100  80  20.8±0.20 
ns  9.2±0.37 
ns  95.6±2.72 
ns  1.64 ±0.084 
ns  100±0.00  
ns 
IIIF (72 mg/kg)  100  100  21.0±0.24 
ns  10.0±0.78 
ns 
100±0.00 
ns  1.67±0.087 
ns  100±0.00  
ns 
IVH (180 
mg/kg) 
100  80  20.6±0.25 
ns  9.6±0.25  
ns  100±0.00 
ns  1.66 ±0.062 
ns  100±0.00  
ns 
Values are Means + SD (N=5). There were no significant different between treated groups and the control as established using one way Analysis of Variance 
(ANOVA).  Mating Index (MI): The number of mated females/Number of females cohabited; Fertility Index (FI): Percentage mated female/Number of 
pregnant females; Gestation Period (GP); Live Birth Index (LBI): Number of live offspring/Number of offspring delivered; Litter weight (LW); Weaning 
Index (WI): Number of offspring at day 21/number of offspring delivered. 
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Table 3: Reproductive indices for female mice mated with male mice treated with 36, 72 and 180 mg/kg PHA for 21 days. 
PHA 
Treatment 
(mg/kg) 
Time taken to 
mating (days) 
№ of 
mice 
mated 
№ of 
Pregnant 
females 
MI (%)  FI 
(%) 
GP (days)  Litter №  LBI (%)  LW (g)  WI (%) 
A (control)  3.2 ± 0.83  5  5  100  100  21.0±0.32  9.2±0.62  100±0.00  1.60± 0.083  100±0.00 
B (36)  3.2 ± 1.09 
ns  5  4  100  80  21.8±0.20 
ns  10.4±0.26 
ns  98.2±1.82 
ns  1.68± 0.080 
ns  100±0.00 
ns 
C (72)  3.4 ± 1.14 
ns  5  5  100  100  21.6±0.24 
ns  10.8±0.42 
ns  100±0.00 
ns  1.63 ± 0.082 
ns  94.8±3.37 
ns 
D (180)  3.4 ± 0.89 
ns  5  5  100  100  21.4±0.24 
ns  10.3±0.45 
ns  100±0.00 
ns  1.64 ± 0.065 
ns  100±0.00 
ns 
Values are Means + SD (N=5). Different between treated groups and the control was established using one way Analysis of Variance (ANOVA); ns imply P > 
0.05. Mating Index (MI): The number of mated females/Number of females cohabited; Fertility Index (FI): Percentage mated female/Number of pregnant 
females; Gestation Period (GP); Live Birth Index (LBI): Number of live offspring/Number of offspring delivered; Litter weight (LW); Weaning Index (WI): 
Number of offspring at day 21/number of offspring delivered. 
 
Table 4: The Effect of 36, 72 and 180 mg/kg PHA treatment on male-specific toxicities in ICR Mice 
Treatments  Paired weight of caudal 
epididymis (mg) 
Paired weight of 
testis (mg) 
Spermatozoa 
concentration 
(x 10
6cells/ml) 
Spermatozoa motility 
(%) 
Spermatozoa 
viability (%) 
Control (untreated)  0.0237 ± 0.004  0.133 ± 0.048  9.22 ± 1.125  93.45 ± 2.734  96.39 ± 2.78 
36 mg/kg PHA  0.0242 ± 0.002 
ns  0.133 ± 0.060 
ns  9.37 ± 0.677 
ns  94.67 ± 2.18 
ns  95.55 ± 2.59 
ns 
72 mg/kg PHA  0.0228 ± 0.004 
ns  0.132 ± 0.021 
ns  10.04 ± 0.448 
ns  92.88 ± 1.96 
ns  97.01 ± 3.49 
ns 
180 mg/kg PHA  0.0245 ± 0.004 
ns  0.134 ± 0.075 
ns  9.86 ± 0.829 
ns  95.82 ± 3.07 
ns  96.02 ± 2.88 
ns 
Values quoted are Means + SD (n=5). Different between treated groups and the control was established using one way Analysis of Variance (ANOVA);  
ns imply P > 0.05. 
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